Multivariate Analysis of Clinical Factors on Overall AML and AML-M5 Patient Survival
| Variable* . | All AML (P) . | AML-M5 (P) . |
|---|---|---|
| Age (≤50/>50 yr) | .037 | .218 |
| Sex (M/F) | .145 | .926 |
| WBC (+Lz50/>50 × 109/L) | .036 | .516 |
| LDH (≥N, ≤5 × N/>5 × N) | .113 | .722 |
| nm23-H1(≤100/>100) | .034 | .003 |
| nm23-H2 (≤110/>110) | .691 | .396 |
| Variable* . | All AML (P) . | AML-M5 (P) . |
|---|---|---|
| Age (≤50/>50 yr) | .037 | .218 |
| Sex (M/F) | .145 | .926 |
| WBC (+Lz50/>50 × 109/L) | .036 | .516 |
| LDH (≥N, ≤5 × N/>5 × N) | .113 | .722 |
| nm23-H1(≤100/>100) | .034 | .003 |
| nm23-H2 (≤110/>110) | .691 | .396 |
*Except the factors of chromosomal aberration, t(15;17) and t(8;21).